NEW YORK, Sept. 13 (UPI) --More than 5 million Americans in treatment for depression could benefit from therapy with psilocybin -- the active ingredient in "magic mushrooms," a new study finds. The ...
The psychedelic and psychedelic-like drug space made another stride as Ataibeckley Inc. disclosed positive top-line data from a double‑blind, placebo‑controlled, first-in-patient phase IIa study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results